Showing results (151-160 of 250) with videos related to
Sort By:
Pageof 25
Breast Cancer Research and Treatment|August 1, 2008
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialGeorge Pentheroudakis, Konstantine T Kalogeras, Ralph M Wirtz, et al.European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trialDirk Schadendorf, Hussein Tawbi, Evan J Lipson, et al.The Journal of Investigative Dermatology|April 8, 2006
Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European populationAlexander J Stratigos, Gerasimos Dimisianos, Vasiliki Nikolaou, et al.Breast Cancer Research and Treatment|July 11, 2006
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survivalLida Kostadima, George Pentheroudakis, George Fountzilas, et al.Acta Dermato-Venereologica|May 19, 2018
CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological ParametersFani Karagianni, Ching-Ni Njauw, Katerina P Kypreou, et al.Journal of Translational Medicine|November 4, 2010
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trialHelen Gogas, Urania Dafni, Henry Koon, et al.Clinical Breast Cancer|May 22, 2012
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expressionEvangelia Razis, Konstantine T Kalogeras, Vassiliki Kotoula, et al.Oncology|January 12, 2008
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyOlympia Tzaida, Helen Gogas, Urania Dafni, et al.Anticancer Research|July 1, 2015
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group TrialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.Breast Cancer Research and Treatment|June 28, 2005
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology GroupGeorge Fountzilas, Dimitrios Pectasides, Anna Kalogera-Fountzila, et al.Pageof 25